QSI Share Price Performance
US$0.86
-0.52 (-37.77%)
78.6% undervalued intrinsic discount
US$4.05
Fair Value
Price US$0.86
AnalystHighTarget US$4.05
AnalystConsensusTarget US$2.68
AnalystLowTarget US$2.00
Fair ValueUS$4.05
Share Pricen/a
Quantum-Si incorporated Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 54 Fair Values set on narratives written by author
QSI Community Narratives
AN
Fair Value US$4.05 78.6% undervalued intrinsic discount
Proteomics Placements And New Platform Pipeline Will Reshape Long-Term Potential
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$2.68 67.8% undervalued intrinsic discount
Single Molecule Protein Sequencing Platforms Will Drive Long Term Proteomics Demand Narrative
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value US$2 56.8% undervalued intrinsic discount
Delayed Commercialization And Slow Consumables Adoption Will Eventually Support Long-Term Proteomics Potential
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Proteomics Placements And New Platform Pipeline Will Reshape Long-Term Potential
Catalysts About Quantum-Si Quantum-Si develops single molecule protein sequencing platforms and consumables for proteomics research across academic, government and commercial labs. What are the underlying business or industry changes driving this perspective?Read more
33
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$4.05
78.6% undervalued intrinsic discount
Fair Value
Profit Margin
15.66%
Future PE
79.76x
Price in 2029
US$5.07
Single Molecule Protein Sequencing Platforms Will Drive Long Term Proteomics Demand Narrative
Catalysts About Quantum-Si Quantum-Si develops single molecule protein sequencing platforms and consumables that enable advanced proteomics research across academic, biopharma and government labs. What are the underlying business or industry changes driving this perspective?Read more
21
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
US$2.68
67.8% undervalued intrinsic discount
Fair Value
Profit Margin
15.66%
Future PE
132.71x
Price in 2028
US$3.36
Delayed Commercialization And Slow Consumables Adoption Will Eventually Support Long-Term Proteomics Potential
Catalysts About Quantum-Si Quantum-Si develops single molecule protein sequencing platforms and consumables that enable high resolution proteomic analysis for research and translational laboratories. What are the underlying business or industry changes driving this perspective?Read more
25
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$2
56.8% undervalued intrinsic discount
Fair Value
Profit Margin
15.5%
Future PE
362.62x
Price in 2028
US$2.5
Trending Discussion
Recently Updated Narratives
AN
Proteomics Placements And New Platform Pipeline Will Reshape Long-Term Potential
Fair Value: US$4.05 78.6% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Single Molecule Protein Sequencing Platforms Will Drive Long Term Proteomics Demand Narrative
Fair Value: US$2.68 67.8% undervalued intrinsic discount
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Delayed Commercialization And Slow Consumables Adoption Will Eventually Support Long-Term Proteomics Potential
Fair Value: US$2 56.8% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Quantum-Si incorporated Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.47
- 47.33%
- -4,160.06%
- 0%
About QSI
- Founded
- 2013
- Employees
- 145
- CEO
- WebsiteView website
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
